First COVID Treatment for Younger Kids is now FDA approved

Mohamad Ali Salloum, PharmD • May 1, 2022

Share

  • Slide title

    Write your caption here
    Button
  • Slide title

    Write your caption here
    Button
  • Slide title

    Write your caption here
    Button
  • Slide title

    Write your caption here
    Button

Remdesivir..


I bet you’ve heard about this molecule during the pandemic.


This molecule was originally approved by FDA in October 2020 for hospitalized patients aged 12 and above. (Their weight should be at least 40 kilograms)


Properties of Remdesivir:


This molecule is an antiviral drug that acts by limiting the SARS-CoV-2 replication. How?


The virus has a machine that can use the human’s cell components to multiply itself. This machine is called the RNA-dependent RNA polymerase.


Remdesivir is a nucleotide prodrug of an adenosine analog. This means that it mimics the function of another molecule that is used by the machine to build the virus. When Remdesivir sits in place of the molecule that was supposed to be in its place, it terminates the RNA transcription prematurely, thus preventing the virus from multiplying itself.


The usual Adverse events that were observed include: nausea, Elevated transaminase levels, Increase in prothrombin time without a change in the international normalized ratio (INR), and hypersensitivity.



Approvals:


Intravenous Remdesivir is approved for treatment of:


-         Mild to moderate Covid-19 in high-risk, non-hospitalized patients (a 3-day course is initiated within 7 days of symptom onset.)

-         Hospitalized patients with Covid-19 (a 5-day course)


FDA expanded the approval for the intravenous Remdesivir where It’s now available as FDA Emergency Use Authorization (EUA) for treatment of COVID-19 in non hospitalized and hospitalized pediatric patients:


-          Weighing 3.5 kg to 40 kg

-         Age <12 years and weighing > 3.5 kg.

-         Children as young as 28 days can be given the medication.



A phase II/III study was done by “Gilead Sciences” and the scientists observed that 75% of the pediatric patients had clinical improvement at day 10, and 85% showed improvement at last assessment. Adverse events were reported in 72% of the children, and 21 % of them had serious adverse event.



The FDA eventually assessed that the safety profile of Remdesivir is similar in pediatric subjects and adults.


Adverse events that were observed in pediatric patients:

Elevated levels of liver enzymes, allergic reactions, fever, shortness of breath, rash, nausea, sweating, or shivering. (2)

As a summary:

Drug Class Anti-Viral
Mechanism of Action Inhibits SARS-CoV-2 RNA-dependent RNA polymerase (RdRp), which is essential for viral replication
Route of Administration Intravenous (IV)
Side effects Nausea, Elevated transaminase levels, Increase in prothrombin time without a change in the international normalized ratio (INR), and hypersensitivity.

List of Services

    • Slide title

      Write your caption here
      Button
    • Slide title

      Write your caption here
      Button
    • Slide title

      Write your caption here
      Button
    • Slide title

      Write your caption here
      Button

    ABOUT THE AUTHOR

    Mohamad-Ali Salloum, PharmD

    Mohamad Ali Salloum LinkedIn Profile

    Mohamad-Ali Salloum is a Pharmacist and science writer. He loves simplifying science to the general public and healthcare students through words and illustrations. When he's not working, you can usually find him in the gym, reading a book, or learning a new skill.

    Share

    Recent articles:

    By Mohamad-Ali Salloum, PharmD July 22, 2026
    Learn how to recover from burnout by rewiring your brain and nervous system. Discover science-backed techniques including breathwork, mindfulness, exercise, cognitive restructuring, psychological flexibility, and motivation rebuilding.
    By Mohamad-Ali Salloum, PharmD July 20, 2026
    Learn the science of recovery, why scrolling isn't rest, how sleep repairs the brain, and why weekends alone don't cure burnout.
    By Mohamad-Ali Salloum, PharmD July 18, 2026
    Burnout is more than stress. Learn how chronic burnout impacts mental health, heart health, immunity, cognition, and overall well-being.
    By Mohamad-Ali Salloum, PharmD July 16, 2026
    Burnout doesn’t happen overnight. Learn the early warning signs—mental, physical, and behavioral—so you can catch burnout before it takes control.
    By Mohamad-Ali Salloum, PharmD July 14, 2026
    Feeling exhausted but work isn’t the problem? Learn how life burnout happens and why your daily responsibilities may be draining you.
    By Mohamad-Ali Salloum, PharmD July 12, 2026
    Think burnout is just stress? Discover how your thoughts, habits, and mindset may be silently driving your exhaustion.
    By Mohamad-Ali Salloum, PharmD July 10, 2026
    Why do you feel tired but wired? Explore the science of burnout, from cortisol imbalance and HPA axis dysfunction to brain and nervous system changes caused by chronic stress.
    By Mohamad-Ali Salloum, PharmD July 8, 2026
    Feeling exhausted even after rest? Learn what burnout is, its warning signs, causes, and how it differs from stress and depression. Understand why burnout is increasing and who is most at risk.
    By Mohamad-Ali Salloum, PharmD July 6, 2026
    References: Dhabhar FS. Effects of stress on immune function: the good, the bad, and the beautiful. Immunol Res. 2014;58(2–3):193–210. [link.springer.com] Tang L, Cai N, Zhou Y, et al. Acute stress induces an inflammation dominated by innate immunity represented by neutrophils. Front Immunol. 2022;13:1014296. [pmc.ncbi.nlm.nih.gov] Alotiby A. Immunology of stress: a review article. J Clin Med. 2024;13(21):6394. [mdpi.com] Haykin H, Rolls A. The neuroimmune response during stress: a physiological perspective. Immunity. 2021;54(9):1933–1947. [cell.com] Gutierrez Nunez S, et al. Chronic stress and autoimmunity: the role of HPA axis and cortisol dysregulation. Int J Mol Sci. 2025;26(20):9994. [pmc.ncbi.nlm.nih.gov] Bae YS, Shin EC. Editorial: Stress and immunity. Front Immunol. 2019;10:245. [pmc.ncbi.nlm.nih.gov]
    By Mohamad-Ali Salloum, PharmD July 4, 2026
    Losing motivation to do sports? Read to find out what is happening with you!
    More Posts